Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
J Pediatr. 2012 Sep;161(3):448-51. doi: 10.1016/j.jpeds.2012.03.003. Epub 2012 Apr 14.

Neonatal benzodiazepines exposure during breastfeeding.

Author information

  • 1Schulich School of Medicine, University of Western Ontario, London, Ontario, Canada.

Abstract

OBJECTIVE:

To assess central nervous system depression and other adverse effects in infants exposed to benzodiazepines through breast milk.

STUDY DESIGN:

A prospectively recruited, retrospectively assessed cohort study of mothers who contacted the Motherisk program regarding the safety of benzodiazepines and were invited to participate in a follow-up program regarding the effects of these medications on their infants during lactation.

RESULTS:

A total of 124 consenting women participated. Adverse outcomes, specifically sedation, was identified in only 1.6% (2 of 124) of infants and was not associated with benzodiazepine dose, number of hours breastfed, or any demographic trait. Mothers reporting adverse outcomes in themselves (26% [32 of 124]) were more likely to be taking concomitantly a greater number of central nervous system depressants.

CONCLUSIONS:

This study supports the continued recommendation to initiate breastfeeding while taking benzodiazepines postpartum.

Copyright © 2012 Mosby, Inc. All rights reserved.

PMID:
22504099
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk